Posts Tagged ‘C’

KEYN unlocks profits, C deals, MIPS mopes

Wednesday, January 26th, 2011

Keynote Systems Inc. (Nasdaq: KEYN) shares rallied 24.6 percent to $18.67, on volume of 330,784 shares, or better than four times its normal daily average. Late Tuesday, the maker of online-monitoring systems reported first-quarter earnings that beat consensus expectations.

Citigroup Inc. (NYSE: C) took its place among the volume leaders early Wednesday, trading in 81.3 million shares, catching up on its full-day average of 553.2 million. Share prices for C were up 0.6 percent to $4.85, on word from the Treasury Dept. that the nation is set to record a net $312.2 million from its sale of its final 465.1 million warrants to purchase common shares of C.

MIPS Technology (Nasdaq: MIPS) dipped 11.6 percent to $13.32 Wednesday. Volume for the stock was 3.5 million shares, already surpassing its daily average of 3 million. Tuesday, MIPS declared it earned $6 million, or 11 cents per share, compared with $3.3 million, or seven cents per share, a year ago.

CLDA jumps, C busy and sells, WWE pinned

Monday, January 24th, 2011

Clinical Data Inc. (Nasdaq: CLDA) shares rallied 57.68 percent Monday to $23.70. Volume was 7,637,288 shares, overwhelming a daily average of 240,736, after the company’s antidepressant received approval Friday from the U.S. Food and Drug Administration.

Citigroup Inc. (NYSE: C) dealt in 104,749,584 shares, compared to its full-day average of 552,485,000. Share prices dipped 0.6 percent at $4.86, on word that today may be the last day of Uncle Sam’s ownership ties to Citigroup.

World Wrestling Entertainment Inc. (NYSE: WWE) shares lost 9.48% to $12.22. Volume for the stock was 791,108, more than twice its full-day average, after the producer of wrestling matches late Friday projected fourth-quarter earnings below expectations.

BLTI climbs, C steady, MNKD manhandled

Thursday, January 20th, 2011

BioLase Technology Inc. (Nasdaq: BLTI) vaulted 80.2 percent in price Thursday to $3.01. Volume of 1,723,791 shares overwhelmed its full-day average of 46,341. Biolase said today it expects to post a profit after four quarters of loss, sending the dental laser company’s shares up 68 percent to a year-high.

Citigroup Inc. (NYSE: C) dealt in 228,816,253 shares, inching toward its full-day average of 551,205,000. Share prices edged higher 0.1 percent to $4.76.

MannKind Corp. (Nasdaq: MNKD) shares tumbled 42.4% to $5.27. Volume was 12,079,531, or four times its full-day average, after the biotechnology company failed to obtain regulatory approval to market its insulin inhaler.

CIMT catches fire, C trades widely, LNET eases off

Wednesday, January 19th, 2011

Cimatron Limited (Nasdaq: CIMT) climbed 17.4 percent to $4.30 Wednesday. Volume of 238,432 shares very nearly quadrupled its full-day volume average, on word CIMT has signed a partnership and distribution agreement with Atometric Inc., a provider of CNC micro-machining centers and contract micro-machining solutions.

Citigroup Inc. (NYSE: C) was a volume leader early Wednesday, trading in 249,690,475 shares, catching up on its full-day average of 554,789,000. Prices for the stock inched up 0.3 percent to $4.82., after Oppenheimer fixed an Outperform rating and $5.50 price target.

LodgeNet Interactive Corporation (Nasdaq: LNET) tanked 24 percent Wednesday to $3.13. Volume for the stock was 1,813,261 shares, seven times its normal daily volume. LNET is the leading provider of media and connectivity solutions designed to meet the unique needs of hospitality, healthcare and other guest-based businesses.

SBIBW has wings, C, ALXA sink

Tuesday, January 18th, 2011

Sterling Bancshares Inc. (Nasdaq: SBIBW) flew 60 percent in price to $3.12. Volume was 101,438, or five times its full-day volume average, amid reports this week that Cullen/Frost Bankers, Inc. may be acquiring the smaller bank.

Citigroup Inc. (NYSE: C) flew off the shelves Tuesday, dealt in 731,126,655 shares Thursday, already surpassing a full-day average of 549,838,000. Prices for C fell 5.5 percent to $4.86. Citigroup reported a $1.3 billion profit, compared with a $7.6 billion loss a year earlier. Revenue jumped to $18.4 billion, from $5.4 billion a year earlier, but fell more than 11% from the third quarter.

Alexza Pharmaceuticals Inc. (Nasdaq: ALXA) fell 19.2 percent in early trading to $1.35. Volume for the stock was 1,784,554 shares, nearly double its all-day average, on word that the company will file a new application for its drug candidate Adusuve Staccato in July.